Deciding on the right HIV prevention method is no longer a one-size-fits-all process, especially with long-acting injectable PrEP options now available. If you’re comparing yeztugo vs apretude or wondering how yeztugo lenacapavir vs apretude cabotegravir stack up, understanding the key differences can help you make a confident, informed choice. From dosing schedules to effectiveness, side effects, and convenience, each option offers unique benefits depending on your lifestyle and preferences. Here’s what you need to know before deciding which injectable PrEP is right for you.
Key Takeaway
- Dosing Frequency: Yeztugo is given twice a year; Apretude is given every two months.
- Effectiveness: Both are highly effective at preventing HIV, outperforming daily pills.
- Injection Type: Yeztugo is a subcutaneous shot (stomach/thigh); Apretude is an intramuscular shot (buttocks).
- Side Effects: Injection-site reactions (temporary soreness and redness) are the most common side effects for both.
- Mandatory Testing: You must test negative for HIV before starting and right before every scheduled injection.
Quick Answer: The Right Injectable PrEP Option Depends on Your Schedule, Preferences, and Follow-Up Needs
When comparing Yeztugo vs Apretude, it is important to know that both are highly effective, FDA-approved injectable PrEP options for reducing the risk of sexually acquired HIV in eligible adults and adolescents weighing at least 35 kg.
The most significant difference between the two medications is their dosing schedule:
- Yeztugo is dosed every 6 months (following an initial oral and injection loading phase).
- Apretude is given as initial injections 1 month apart, and then every 2 months thereafter.
The “best” injectable PrEP isn’t necessarily the newest medication. The right choice is the one you’re most likely to start, stay consistent with, and complete follow-up visits for.
For many people, the decision comes down to practical factors such as how often you’re willing to visit a clinic, comfort with the injection schedule, and guidance from your healthcare provider.
If You Want Fewer Dosing Visits, Yeztugo May Stand Out
When comparing twice-yearly PrEP vs every-2-month PrEP, the dosing schedule is often the biggest deciding factor. Yeztugo (lenacapavir) stands out as the first and only twice-yearly injectable PrEP option in the U.S., offering a more spaced-out routine.
This extended interval can be especially appealing if you want long-lasting, discreet protection without needing to visit a clinic every other month, as required with Apretude (cabotegravir).
However, fewer injections does not mean less care. Both options require consistent medical follow-up, including HIV testing before each dose to confirm a negative status. Even with Yeztugo’s longer dosing gap, routine check-ins, safety monitoring, and STI screenings remain essential parts of staying protected and maintaining your overall sexual health.
What’s the Difference Between Yeztugo and Apretude?
For a quick and easy injectable PrEP comparison, here is a direct look at Yeztugo vs Apretude and how their core features stack up against each other:
| Feature | Yeztugo (lenacapavir) | Apretude (cabotegravir) |
| Drug Class | Lenacapavir (capsid inhibitor) | Cabotegravir (Integrase Strand Transfer Inhibitor / INSTI) |
| Administration | Subcutaneous injection (under the skin of the abdomen or thigh) | Intramuscular injection (deep into the gluteal muscle/buttocks) |
| Maintenance Schedule | Every 6 months (twice a year) | Every 2 months (six times a year) |
| HIV Testing Requirement | Mandatory negative test before initiation and every subsequent injection | Mandatory negative test before initiation and every subsequent injection |
Dosing Schedule May Be the Biggest Practical Difference
When choosing between a twice yearly prep vs every 2 month prep, the schedule is often the deciding factor for patients. Here is the practical breakdown for Apretude vs Yeztugo:
- Yeztugo (Every 6 Months): Begins with an initial oral and injection loading phase, followed by maintenance injections just twice a year.
- Apretude (Every 2 Months): Offers an optional 30-day oral lead-in, starts with two initial injections one month apart, and then requires maintenance injections every 60 days.
Yeztugo vs Apretude: Which Injectable PrEP Option Fits Your Lifestyle Better?
When deciding which injectable PrEP is right for you, it is crucial to look at your actual day-to-day routine. The best injectable PrEP option isn’t based on an idealized version of your schedule, it is the one that is realistic for you to maintain.
- For Minimal Interruptions: People who want the absolute fewest injection appointments will likely prefer Yeztugo’s twice-a-year schedule.
- For a Steady Routine: People who are comfortable with a more established, routine rhythm might prefer Apretude’s every-2-month schedule.
Your decision may also depend on practical factors like travel, work schedule, access to a clinic, and how consistent you can be with follow-up visits. The “right” option isn’t the most appealing on paper, it’s the one you can stick with long term.
Think in Terms of Adherence, Not Just Convenience
In any injectable PrEP comparison, the clear winner is always the medication you can actually stick with. Adherence is everything, and missed visits matter significantly when relying on long-acting injections to protect your health.
Finding the best injectable PrEP option means knowing your own habits:
- Avoiding Drop-Off: A less frequent schedule (Yeztugo) can be a lifesaver for those who experience “appointment fatigue” and might otherwise abandon their treatment plan.
- Staying Engaged: Conversely, a more frequent schedule (Apretude) helps some people stay consistently engaged with their healthcare, providing regular check-ins and peace of mind.
Ultimately, this choice should be highly individualized through an honest conversation with your healthcare provider to ensure you stay protected year-round.
Who Might Prefer Yeztugo (lenacapavir)?
When comparing Yeztugo (lenacapavir) vs Apretude (cabotegravir), the frequency of your required clinic visits is often the ultimate deciding factor. Among the available injectable PrEP options, Yeztugo is generally the preferred choice for:
- People who want longer spacing between their required doses.
- People who dislike frequent appointments or have busy schedules that make clinic visits difficult.
- People looking specifically for a twice-yearly option to reduce healthcare fatigue.
- People who want the reliability of injectable PrEP but worry they might struggle to stay consistent on a strict, every-2-month cycle.
Yeztugo May Appeal Most to “Set It and Remember It” Users
In the ongoing discussion of Yeztugo vs Apretude, the sheer convenience of a twice yearly prep vs every 2 month prep schedule cannot be overstated. Requiring fewer annual injections is a major lifestyle benefit, making Yeztugo a fantastic fit for people who want less frequent dosing interruptions in their day-to-day lives.
However, “less frequent” does not mean “zero effort.” Even on a six-month injection schedule, mandatory HIV testing, proactive appointment scheduling, and consistent follow-up communication with your healthcare provider remain absolutely essential to safely maintain your PrEP prescription.
Who Might Prefer Apretude (cabotegravir)?
In the debate of Apretude vs Yeztugo, the established history and steady schedule of Apretude make it a highly reliable choice. When looking at your injectable PrEP options, Apretude is often the preferred choice for:
- People comfortable returning to their healthcare provider for injections every 2 months.
- People already familiar with cabotegravir-based PrEP discussions and its clinical profile.
- People whose current care setting already readily offers Apretude as a standard option.
- People who want a proven track record, prioritizing an injectable medication that has been FDA-approved for PrEP since 2021.
Apretude May Work Well for People Who Like a More Regular Check-In Rhythm
When weighing lenacapavir vs cabotegravir prep to determine which injectable prep is right for you, it helps to consider how you naturally manage your health routines.
For many patients, a more frequent dosing schedule actually creates a steady, predictable care routine. Some people simply feel better—and more secure in their sexual health—with regular provider contact and routine check-ins. Ultimately, the best choice may depend entirely on how you personally manage appointments, calendar reminders, and ongoing healthcare commitments.
Safety and Monitoring: What Both Injectable PrEP Options Have in Common
When doing an injectable PrEP comparison, it becomes clear that the safety protocols for Yeztugo vs Apretude are virtually identical.
First and foremost, strict HIV testing is required before starting either medication and continually during their use. Neither option should ever be treated like a “one-and-done” shot. Ongoing sexual health monitoring, including routine STI testing and regular provider follow-up, remains a core part of your comprehensive PrEP care. Most importantly, both medications carry severe boxed warnings regarding the risk of drug resistance if the injections are used by someone with an undiagnosed HIV infection.
Injectable PrEP Is Lower-Maintenance Than Daily Pills, Not No-Maintenance
When determining which injectable PrEP is right for you, it is crucial to set your expectations correctly from day one.
While finding the best injectable PrEP option for your lifestyle will significantly reduce your daily pill burden, it does not mean your sexual healthcare is now “no-maintenance.” Injections completely remove the stress of remembering a daily pill, but they do not eliminate the need for mandatory HIV testing, routine lab work, or consistent provider follow-up, whether those check-ins are done at a traditional clinic or safely managed through an online telehealth platform.
Effectiveness: Are Yeztugo and Apretude Both Strong PrEP Options?
When evaluating Yeztugo vs Apretude, it is important to look beyond the headline numbers. Both of these injectable PrEP options provide top-tier protection, and the right choice depends heavily on your lifestyle rather than just clinical percentages.
Here is a breakdown of how to view the effectiveness of both options:
| Effectiveness Factor | What You Need to Know |
| Baseline Efficacy | The CDC states that all FDA-approved PrEP options are highly effective at preventing HIV when taken exactly as prescribed. |
| Yeztugo (lenacapavir) Data | The CDC’s 2025 recommendation cited remarkable trial efficacy for lenacapavir: 100% in one study population and 96% in a primarily male trial population over 52 weeks (compared with estimated background HIV incidence). |
| How to Compare Them | Avoid framing this comparison as a simplistic “winner” and “loser.” Both medications offer incredible, life-saving protection. |
| The Real “Winner” | Ultimately, clinical fit and adherence matter far more than headline comparison language. A medication is only effective if it fits your life well enough that you never miss a dose. |
“More Effective” Isn’t Always the Most Useful Question
When comparing lenacapavir vs cabotegravir prep, asking which drug is “more effective” is rarely the right starting point. Ultimately, the best injectable PrEP option is simply the one you can reliably stay on schedule with.
A highly effective medication only works if you actually receive your injection on time. Whether you visit a local clinic every two months or use an online platform to safely coordinate your twice-yearly PrEP care, what matters most is your consistency. Both of these medications offer incredible protection against HIV, so your choice should be grounded in the reality of your routine, rather than overclaiming the comparative superiority of one drug over the other.
Practical Questions to Ask Before Choosing Between Yeztugo and Apretude
To make the most useful injectable PrEP comparison, it helps to step back from the clinical data and look at your actual day-to-day life. Figuring out which injectable PrEP is right for you often comes down to answering a few straightforward lifestyle questions.
Here is a quick checklist of what to consider before making your decision:
| Practical Question | What to Consider |
| How often am I realistically willing to come in? | Be honest with yourself about your work schedule, travel habits, and general tolerance for making and keeping medical appointments. |
| Do I want fewer injections each year? | If minimizing needle pricks and reducing healthcare fatigue is your top priority, a twice-yearly schedule might be the clear winner. |
| Am I okay with the start-up schedule for either option? | Both medications require a specific initiation phase (like Yeztugo’s pill-and-shot starter days or Apretude’s initial one-month gap). Ensure you are prepared for that initial hurdle. |
| What kind of follow-up support does my provider offer? | Consider whether you need regular in-person reassurance from a doctor or if you are comfortable managing your lab reminders and ongoing check-ins independently. |
| Which option is actually available through my care pathway? | Not all clinics stock both medications yet. You will need to verify whether your local provider or telehealth platform can actually prescribe and manage the specific injection you want. |
Taking the Next Step: If you’re comparing PrEP options, it helps to start with a provider that clearly explains testing, prescriptions, and ongoing follow-up. You can review MISTR’s process.
Common Misunderstandings About Injectable PrEP Options
When exploring the available injectable PrEP options, especially during conversations about Yeztugo vs Apretude, it is easy for misconceptions to arise. To make an informed decision, it helps to clear up these common myths:
- “Injectable” does not mean no HIV testing: Whether you get a shot twice a year or six times a year, mandatory HIV testing is required right before every single injection to ensure your safety and prevent severe drug resistance.
- Fewer injections do not mean zero appointments: Spacing out your doses is convenient, but it does not eliminate the need for routine check-ins, lab work, STI screenings, and ongoing communication with your healthcare provider.
- Newer does not automatically mean better for every person: While Yeztugo is the newest medication on the market, Apretude’s established routine might actually be a better clinical and practical fit for certain patients.
- The “best” option is highly personal: Ultimately, your decision depends on individual fit, reliable access to the medication, and your ability to maintain consistent follow-up care.
Don’t Choose Based on Frequency Alone
It is incredibly tempting to look at a twice-yearly prep vs every 2 month prep schedule and immediately pick the one with the fewest visits. While injection timing absolutely matters, it should not be the only factor driving your choice.
Finding the best injectable PrEP option for your life requires looking at the bigger picture. Provider support, clinic logistics, prescription access, and your own history of consistency with medical appointments all play a massive role in your long-term success. The goal is to choose a sustainable, realistic routine that keeps you safely protected, rather than oversimplifying a vital healthcare decision down to just a timeline.
FAQs: Yeztugo vs Apretude
Q1: What’s the difference between Yeztugo and Apretude?
The main difference is the schedule and injection type: Yeztugo is injected under the skin every 6 months, while Apretude is an intramuscular injection given every 2 months.
Q2: Is Yeztugo better than Apretude?
Not necessarily. Both are highly effective, and the better option depends on which schedule and follow-up routine you’re more likely to stick with.
Q3: How often do you get Yeztugo vs Apretude?
Yeztugo is given every 6 months (after initiation), while Apretude is given every 2 months after the first two starter injections.
Q4: Is Yeztugo the same as cabotegravir?
No. Yeztugo contains lenacapavir, while Apretude contains cabotegravir, they are different drugs that work in different ways.
Q5: Which injectable PrEP lasts longer?
Yeztugo lasts longer between doses, with twice-yearly injections, compared to Apretude’s every-2-month schedule.
Q6: Do both Yeztugo and Apretude require HIV testing?
Yes. HIV testing is required before and during treatment for both medications to ensure safety and prevent drug resistance.
Q7: Who is a better candidate for twice-yearly PrEP?
People who prefer fewer clinic visits and feel confident managing less frequent appointments may prefer Yeztugo, as long as they can still stay consistent with follow-up care.
Q8: How do I choose the right injectable PrEP option?
Focus on what fits your life: visit frequency, access to care, comfort with the schedule, and provider support. The best option is the one you can realistically maintain over time.